More about

Allergic Conjunctivitis

News
August 09, 2024
2 min read
Save

Long-term dupilumab safe, efficacious in atopic dermatitis

Dupilumab showed continuous efficacy and safety in the long-term treatment of atopic dermatitis, according to a study.

News
February 19, 2024
4 min watch
Save

VIDEO: Dextenza demonstrates positive real-world safety

TAMPA, Fla. — In this Healio Video Perspective from Telling It Like It Is, Steven M. Silverstein, MD, FACS, discusses safety data for Dextenza for the treatment of perioperative ocular pain and inflammation and allergic conjunctivitis.

News
February 19, 2024
1 min read
Save

Harrow licenses 5 ophthalmic products to Canada-based Apotex

Harrow has announced an exclusive out-licensing agreement with Apotex, a major Canadian pharmaceutical company, to market and distribute five of the company’s branded ophthalmic products.

News
November 18, 2023
1 min read
Save

European Commission approves Ebglyss for adults, adolescents with atopic dermatitis

The European Commission has approved Ebglyss in the European Union for the treatment of moderate to severe atopic dermatitis in adults and adolescents aged 12 years and older, Almirall announced in a press release.

News
October 31, 2023
3 min read
Save

BLOG: Perioperative optimization of cross-linking patients

For patients with progressive keratoconus, corneal cross-linking is indicated to slow or stop the progression of the disease.

News
July 25, 2023
1 min read
Save

Verséa Ophthalmics launches tear-based, point-of-care immunoassay kit for ocular disease

Verséa Ophthalmics announced the distribution of its T-POC Total IgE Immunoassay Kit, a tear-based point-of-care test for the diagnosis and management of ocular surface disease.

News
November 07, 2022
2 min read
Save

Physical fitness associated with reduced risk for allergic conjunctivitis in children

Children who are more physically fit than their peers experience reduced risk for allergic conjunctivitis, according to a study presented at American Academy of Ophthalmology 2022.

News
October 28, 2022
1 min read
Save

Pataday drop relieves ocular itching better than Claritin tablet

SAN DIEGO — A comparison of over-the-counter Pataday drops with OTC Claritin tablets at 15 minutes and 24 hours showed that the drops were more effective at relieving ocular itching in patients with allergic conjunctivitis.

News
October 25, 2022
2 min read
Save

E-diaries show promise for collecting allergic rhinoconjunctivitis symptoms

Patients remember allergic rhinoconjunctivitis symptom frequency with less precision than they remember symptom severity, although prospective and retrospective assessments of severity are well interrelated, according to a study.

News
April 26, 2022
1 min read
Save

Dextenza shows sustained effect in allergic conjunctivitis

WASHINGTON — Patients who underwent Dextenza implantation had improvements in itching due to allergic conjunctivitis through 30 days, according to a study.

View more